Burford speaks to IAM on the role of legal finance for pharmas facing patent disputes

March 17, 2020

Katharine Wolanyk and Joshua Harris outline to IAM Magazine how to secure legal finance for pharma companies involved in IP litigation.

Read the full article here.

This material has been prepared by Burford Capital Limited (together with its subsidiaries, “Burford Capital”) solely for informational purposes, is not intended to be relied upon as a forecast, research or investment advice and is not a recommendation, offer or solicitation to subscribe for, buy or sell any securities, products or services or to adopt any investment strategy. The opinions expressed in this material are as of the date of this material and are subject to change at any time without notice, and Burford Capital does not have any responsibility to update this material to account for such changes. Unless otherwise specified, information contained in this material is sourced from and reflects the views and opinions of Burford Capital. Certain information contained in this material has been obtained from sources other than Burford Capital. While such information is believed to be reliable for purposes used in this material, no representation or warranty, either express or implied, is made as to fairness, accuracy, reasonableness or completeness thereof, and Burford Capital does not take any responsibility for such information. Certain information contained in this material discusses general market activity, industry or sector trends or other broad-based economic, market or political conditions and should not be construed as research or investment advice. There can be no assurances that any of the trends described in this material will continue or will not reverse. Past events and trends do not imply, predict or guarantee, and are not necessarily indicative of, future events or results. The information contained in this material is not intended to provide, and should not be relied upon for, accounting, legal or tax advice or investment recommendations. Reliance upon information in this material is at the sole discretion of the reader.

This material may contain “forward-looking statements”. Although Burford Capital believes that the assumptions, expectations, projections, intentions and beliefs about future results and events reflected in forward-looking statements have a reasonable basis and are expressed in good faith, forward-looking statements involve known and unknown risks, uncertainties and other factors, which could cause Burford Capital’s actual results and events to differ materially from (and be more negative than) future results and events expressed, targeted, projected or implied by these forward-looking statements. The forward-looking statements speak only as of the date of this material and, except as required by applicable law, Burford Capital undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Burford speaks to IAM on the role of legal finance for pharmas facing patent disputes

The latest from Burford

Get in touch